glp-1 weight loss drugs news today Chart: 1 in 8 Americans Now Use for Study: GLP-1 Weight Loss Drugs
Description
Janet Klein, MS RDN, CDN, CDCES, Bariatric Surgery and Obesity Medicine Program Director
Key Findings: - Increased risk of going over recommended weight gain limits - Higher chances of preterm birth (from 13% to 17%) - Rising cases of gestational diabetes (15% to 20%) - Nearly half faced high blood pressure issues While baby sizes and C-section rates remained similar, the impact on maternal health is significant
Ozempic alternatives in the GLP-1 family offer effective weight loss pathways
This drug, indicated for glycemic control in patients aged 10 years and above with type 2 diabetes, serves as an adjunct to diet and exercise
Shima Hadidchi, MD, in Apple Valley and Victorville, CA
Quality Assurance & Verification
